Do nonobese patients with Behcet's disease have insulin resistance?

dc.authorid0000-0001-6259-0219
dc.authorid0000-0002-4392-4671
dc.authorid0000-0003-2806-2636
dc.contributor.authorKahraman, Filiz Cebeci
dc.contributor.authorKayatas, Kadir
dc.contributor.authorErdogan, Sevil Savas
dc.contributor.authorOnsun, Nahide
dc.date.accessioned2025-05-10T19:40:15Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground Some studies have investigated the relationship between Behcet's disease (BD) and insulin resistance; however, since they did not exclude obese patients from their sample, it remains unclear whether BD itself causes insulin resistance independently of obesity. Methods The study included 60 patients with BD and 45 age-, gender-, and body mass index (BMI)-matched healthy controls. Obese patients with a BMI of >= 30 kg/m(2) were excluded. Insulin resistance according to the homeostasis model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI), fasting plasma glucose, and one-hour and two-hour plasma glucose in the oral glucose tolerance test (OGTT 1-h and OGTT 2-h PG, respectively) were evaluated in all patients. Results The mean fasting plasma glucose levels and the rate of those with impaired glucose tolerance according to OGTT 2-h PG were significantly higher in the BD patients compared to the controls. The rates of those with insulin resistance according to HOMA-IR and QUICKI were significantly higher in the BD patients than in the controls. When compared to the control group, the rates of those with impaired fasting glucose and impaired glucose tolerance were significantly higher, and the mean QUICKI value was significantly lower in the active group, in contrast to the inactive group. Conclusions Insulin resistance occurs in BD patients independently of obesity. In the follow-up of BD patients, especially in the active phase, not only fasting blood glucose but also other diagnostic tests for insulin resistance should be added to the examination panels.
dc.identifier.doi10.1111/jocd.14276
dc.identifier.endpage1694
dc.identifier.issn1473-2130
dc.identifier.issn1473-2165
dc.identifier.issue4
dc.identifier.pmid34087034
dc.identifier.scopus2-s2.0-85107914533
dc.identifier.scopusqualityQ2
dc.identifier.startpage1688
dc.identifier.urihttps://doi.org/10.1111/jocd.14276
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9930
dc.identifier.volume21
dc.identifier.wosWOS:000661715600001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofJournal of Cosmetic Dermatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectBehcet's disease
dc.subjectglucose tolerance
dc.subjectHOMA-IR
dc.subjectinsulin resistance
dc.titleDo nonobese patients with Behcet's disease have insulin resistance?
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9930.pdf
Boyut:
472.56 KB
Biçim:
Adobe Portable Document Format